{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:14:29Z","timestamp":1769818469323,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"am","delay-in-days":312,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jogoh.2022.102329","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T12:17:48Z","timestamp":1643631468000},"page":"102329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Is cell-free fetal DNA testing a safe option for women in a high-risk population after combined first-trimester testing?"],"prefix":"10.1016","volume":"51","author":[{"given":"Matthieu","family":"Dap","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Caffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estelle","family":"Perdriolle-Galet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Morel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogoh.2022.102329_bib0001","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. D\u00e9cision n\u00b0 2018.0243\/DC\/SCI\/SEESP du 19 d\u00e9cembre 2018 du coll\u00e8ge de la Haute Autorit\u00e9 de sant\u00e9 portant adoption d'un document d'information relatif au d\u00e9pistage de la trisomie 21 et de sa m\u00e9thode d\u2019\u00e9laboration."},{"issue":"1","key":"10.1016\/j.jogoh.2022.102329_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010002","article-title":"Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis","volume":"6","author":"Taylor-Phillips","year":"2016","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.jogoh.2022.102329_bib0003","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/aogs.13047","article-title":"Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population\u2014a systematic review and meta-analysis","volume":"96","author":"Iwarsson","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"10.1016\/j.jogoh.2022.102329_bib0004","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/uog.14791","article-title":"Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis","volume":"45","author":"Gil","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"14","key":"10.1016\/j.jogoh.2022.102329_bib0005","doi-asserted-by":"crossref","first-page":"319","DOI":"10.21037\/atm.2019.06.70","article-title":"Lower detectability of non-invasive prenatal testing compared to prenatal diagnosis in high-risk pregnant women","volume":"7","author":"Wang","year":"2019","journal-title":"Ann Transl Med"},{"issue":"4","key":"10.1016\/j.jogoh.2022.102329_bib0006","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/uog.17548","article-title":"Chromosomal microarray as primary diagnostic genomic tool for pregnancies at increased risk within a population-based combined first-trimester screening program","volume":"51","author":"Vogel","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.jogoh.2022.102329_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.12.025","article-title":"Chromosomal abnormalities not currently detected by cell-free fetal DNA: a retrospective analysis at a single center","volume":"214","author":"Shani","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.jogoh.2022.102329_bib0008","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/uog.14636","article-title":"Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis","volume":"45","author":"Akolekar","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.jogoh.2022.102329_bib0009","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1471-0528.1993.tb12973.x","article-title":"Low maternal serum levels of pregnancy associated plasma protein A (PAPP-A) in the first trimester in association with abnormal fetal karyotype","volume":"100","author":"Brambati","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.jogoh.2022.102329_bib0010","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/uog.5299","article-title":"A mixture model of nuchal translucency thickness in screening for chromosomal defects","volume":"31","author":"Wright","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.jogoh.2022.102329_bib0011","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/GCO.0b013e3283372352","article-title":"Ethical challenges in providing noninvasive prenatal diagnosis","volume":"22","author":"Benn","year":"2010","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.jogoh.2022.102329_bib0012","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3390\/jcm9082466","article-title":"Strategy for use of genome-wide non-invasive prenatal testing for rare autosomal aneuploidies and unbalanced structural chromosomal anomalies","volume":"9","author":"Kleinfinger","year":"2020","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.jogoh.2022.102329_bib0013","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11427-017-9344-7","article-title":"Genome-wide detection of additional fetal chromosomal abnormalities by cell-free DNA testing of 15,626 consecutive pregnant women","volume":"62","author":"Yao","year":"2019","journal-title":"Sci China Life Sci"},{"issue":"12","key":"10.1016\/j.jogoh.2022.102329_bib0014","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/gim.2017.56","article-title":"Genome-wide cfDNA screening: clinical laboratory experience with the first 10,000 cases","volume":"19","author":"Ehrich","year":"2017","journal-title":"Genet Med"},{"issue":"11","key":"10.1016\/j.jogoh.2022.102329_bib0015","article-title":"Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women","volume":"11","author":"Badeau","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.jogoh.2022.102329_bib0016","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/gim.2017.132","article-title":"Origin and clinical relevance of chromosomal aberrations other than the common trisomies detected by genome-wide NIPS: results of the TRIDENT study","volume":"20","author":"Van Opstal","year":"2018","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.jogoh.2022.102329_bib0017","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/uog.22021","article-title":"Clinical utility of expanded non-invasive prenatal screening and chromosomal microarray analysis in high-risk pregnancy","volume":"57","author":"Zhu","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.jogoh.2022.102329_bib0018","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jama.2018.9396","article-title":"Effect of cell-free DNA screening vs direct invasive diagnosis on miscarriage rates in women with pregnancies at high risk of trisomy 21: a randomized clinical trial","volume":"320","author":"Malan","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jogoh.2022.102329_bib0019","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/uog.15820","article-title":"Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147,987 singleton pregnancies","volume":"47","author":"Wulff","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.jogoh.2022.102329_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153147","article-title":"Women's experiences and preferences for service delivery of non-invasive prenatal testing for aneuploidy in a public health setting: a mixed methods study","volume":"11","author":"Lewis","year":"2016","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.jogoh.2022.102329_bib0021","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.1062","article-title":"Women's attitudes toward invasive and noninvasive testing when facing a high risk of fetal down syndrome","volume":"2","author":"Seror","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.jogoh.2022.102329_bib0022","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/pd.4608","article-title":"Position statement from the chromosome abnormality screening committee on behalf of the board of the international society for prenatal diagnosis","volume":"35","author":"Benn","year":"2015","journal-title":"Prenat Diagn"},{"issue":"11","key":"10.1016\/j.jogoh.2022.102329_bib0023","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/gim.2012.68","article-title":"Women's and health professionals' preferences for prenatal tests for down syndrome: a discrete choice experiment to contrast noninvasive prenatal diagnosis with current invasive tests","volume":"14","author":"Hill","year":"2012","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.jogoh.2022.102329_bib0024","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/aogs.13841","article-title":"Current use of noninvasive prenatal testing in Europe, Australia and the USA: a graphical presentation","volume":"99","author":"Gadsb\u00f8ll","year":"2020","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784722000216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784722000216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T10:00:08Z","timestamp":1762855208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784722000216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2468784722000216"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2022.102329","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is cell-free fetal DNA testing a safe option for women in a high-risk population after combined first-trimester testing?","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2022.102329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102329"}}